GO
Loading...

Acorda CEO: Interested in therapy for diabetic pain

Thursday, 1 Aug 2013 | 6:58 PM ET

Acorda CEO Dr. Ron Cohen discusses his talks with the FDA about a clinical trial for stroke victims, and its work on developing a product for diabetic pain.